Insights

Insights From Our Experts

Articles

Webinar: Drug Pricing and Reporting Regulatory Updates Part 1

Pharmaceutical companies in the U.S. are navigating President Biden’s new administration and legislative changes that are affecting pricing and regulatory actions.   One of these changes includes the regulatory freeze ordered for actions made in the final two months of…

Watch Now: PharmaVOICE Panel on Next-Gen Patient Services Models

The Future of Data-Driven Patient Support Is Now The use of health data technologies and analytics in the life sciences industry continues to evolve, but many manufacturers are still crawling around in the dark. With limited…

Global Shifts in Legislative Regulation Are Forcing Pharma Back to the Drawing Board : February 2021

In only a short time this year, the pharmaceutical industry is witnessing new regulations and legislative changes going into effect globally – and the growing pains are setting in.   Between the new U.S. administration and E.U. Pharmaceutical Strategy, governmental entities…

BLOG: Population Health Leadership

“Population health” is the result of pushing health systems to be clinically and financially responsible for their communities. This is a significant shift from simply being focused on the volume of services delivered within the hospital.  The focus on population health represents a movement for pharma from…

Leveraging RWE to Enhance Experiences Across the Patient Journey

In a tech-driven healthcare ecosystem in which patients are engaged consumers, product value is contingent on treatment outcomes and patient success. With digital tools and resources at their fingertips, today’s patient is empowered to make informed…

Reinventing Launch: The Gold Standard Of Drug Commercialization

In a world that is rapidly changing, we must evolve beyond traditional strategies to create true impact for patients. EVERSANA's complete end-to-end commercialization model enables manufacturers to bring their drug to market at a fraction of…

The Crush: How Covid-19 Is Impacting Mature Brand Revenue & Long-Term Value

The impact of COVID is reverberating across all aspects of society and business. In the healthcare industry, hundreds of thousands of patients are not getting proper access to and utilization of therapies that can improve their…

Reimbursement May Be on the Way for Remote Therapeutic Monitoring

The American Medical Association (AMA) manages the procedure code set that physicians and other healthcare professionals use to identify the services for which they bill. These codes are commonly known as the CPT® code set, which…

BLOG: “Payvider” Growth Continues — But Not From the Payers

“Payviders” is the term used to describe the coming together of both payers and providers. In the past several years this has been driven primarily by provider consolidation. As these providers have grown into large, sophisticated groups or wind up under health systems, they seek out risk — serving…

How to Determine Price and Global Launch Sequence in a Post-COVID World

“Just because you’ve launched, it doesn’t mean you can relax. You always need to have your ear to the ground globally as to what’s going on.” —Ed Corbett, Head of EMEA, EVERSANA™ MANAGEMENT CONSULTING The globe…